+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Plasma Fractionation Market 2024-2028

  • PDF Icon

    Report

  • 163 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5923888
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The plasma fractionation market is forecasted to grow by USD 10.00 bn during 2023-2028, accelerating at a CAGR of 6.09% during the forecast period. The report on the plasma fractionation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of plasma products treated in respiratory diseases and AATD, a growing list of plasma-derived products, and an increase in M and A for producing plasma-based products.

The plasma fractionation market is segmented as below:

By Product

  • Immunoglobulins
  • Albumin
  • Coagulation factor concentrates
  • Protease inhibitors
  • Others

By Application

  • Immunology
  • Neurology
  • Hematology
  • Critical care
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing elderly population and related disorders as one of the prime reasons driving the plasma fractionation market growth during the next few years. Also, government strategies for increasing self-sufficiency for plasma products and rising demand for plasma collection will lead to sizable demand in the market.

The report on the plasma fractionation market covers the following areas:

  • Plasma fractionation market sizing
  • Plasma fractionation market forecast
  • Plasma fractionation market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma fractionation market vendors that include ADMA Biologics Inc., Bharat Serums and Vaccines Ltd., CSL Ltd., Emergent BioSolutions Inc., GC Biopharma corp. , Grifols SA, Hemarus Plasma, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion S.p.A, LFB SA, Merck KGaA, Mitsubishi Chemical Group Corp., Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions Netherlands BV, Sanquin, SK Inc., Takeda Pharmaceutical Co. Ltd., and Virchow Laboratories Ltd.. Also, the plasma fractionation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global plasma fractionation market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global plasma fractionation market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Immunoglobulins - Market size and forecast 2023-2028
Exhibit 34: Chart on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Immunoglobulins - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Immunoglobulins - Year-over-year growth 2023-2028 (%)
6.4 Albumin - Market size and forecast 2023-2028
Exhibit 38: Chart on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Albumin - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Albumin - Year-over-year growth 2023-2028 (%)
6.5 Coagulation factor concentrates - Market size and forecast 2023-2028
Exhibit 42: Chart on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
6.6 Protease inhibitors - Market size and forecast 2023-2028
Exhibit 46: Chart on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Protease inhibitors - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Protease inhibitors - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 56: Chart on Application - Market share 2023-2028 (%)
Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
7.3 Immunology - Market size and forecast 2023-2028
Exhibit 60: Chart on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Immunology - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
7.4 Neurology - Market size and forecast 2023-2028
Exhibit 64: Chart on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
7.5 Hematology - Market size and forecast 2023-2028
Exhibit 68: Chart on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Hematology - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Hematology - Year-over-year growth 2023-2028 (%)
7.6 Critical care - Market size and forecast 2023-2028
Exhibit 72: Chart on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Data Table on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibit 74: Chart on Critical care - Year-over-year growth 2023-2028 (%)
Exhibit 75: Data Table on Critical care - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Exhibit 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 78: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Application
Exhibit 80: Market opportunity by Application ($ billion)
Exhibit 81: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 85: Chart on Geographic comparison
Exhibit 86: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 115: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 116: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 117: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 118: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 125: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 127: Overview on factors of disruption
11.4 Industry risks
Exhibit 128: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 129: Vendors covered
12.2 Market positioning of vendors
Exhibit 130: Matrix on vendor position and classification
12.3 ADMA Biologics Inc.
Exhibit 131: ADMA Biologics Inc. - Overview
Exhibit 132: ADMA Biologics Inc. - Business segments
Exhibit 133: ADMA Biologics Inc. - Key offerings
Exhibit 134: ADMA Biologics Inc. - Segment focus
12.4 Bharat Serums and Vaccines Ltd.
Exhibit 135: Bharat Serums and Vaccines Ltd. - Overview
Exhibit 136: Bharat Serums and Vaccines Ltd. - Product / Service
Exhibit 137: Bharat Serums and Vaccines Ltd. - Key offerings
12.5 CSL Ltd.
Exhibit 138: CSL Ltd. - Overview
Exhibit 139: CSL Ltd. - Business segments
Exhibit 140: CSL Ltd. - Key offerings
Exhibit 141: CSL Ltd. - Segment focus
12.6 Emergent BioSolutions Inc.
Exhibit 142: Emergent BioSolutions Inc. - Overview
Exhibit 143: Emergent BioSolutions Inc. - Product / Service
Exhibit 144: Emergent BioSolutions Inc. - Key news
Exhibit 145: Emergent BioSolutions Inc. - Key offerings
12.7 GC Biopharma corp.
Exhibit 146: GC Biopharma corp. - Overview
Exhibit 147: GC Biopharma corp. - Product / Service
Exhibit 148: GC Biopharma corp. - Key offerings
12.8 Grifols SA
Exhibit 149: Grifols SA - Overview
Exhibit 150: Grifols SA - Business segments
Exhibit 151: Grifols SA - Key offerings
Exhibit 152: Grifols SA - Segment focus
12.9 Intas Pharmaceuticals Ltd.
Exhibit 153: Intas Pharmaceuticals Ltd. - Overview
Exhibit 154: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 155: Intas Pharmaceuticals Ltd. - Key offerings
12.10 Kedrion S.p.A
Exhibit 156: Kedrion S.p.A - Overview
Exhibit 157: Kedrion S.p.A - Product / Service
Exhibit 158: Kedrion S.p.A - Key offerings
12.11 LFB SA
Exhibit 159: LFB SA - Overview
Exhibit 160: LFB SA - Product / Service
Exhibit 161: LFB SA - Key offerings
12.12 Merck KGaA
Exhibit 162: Merck KGaA - Overview
Exhibit 163: Merck KGaA - Business segments
Exhibit 164: Merck KGaA - Key news
Exhibit 165: Merck KGaA - Key offerings
Exhibit 166: Merck KGaA - Segment focus
12.13 Mitsubishi Chemical Group Corp.
Exhibit 167: Mitsubishi Chemical Group Corp. - Overview
Exhibit 168: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 169: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 170: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Octapharma AG
Exhibit 171: Octapharma AG - Overview
Exhibit 172: Octapharma AG - Product / Service
Exhibit 173: Octapharma AG - Key offerings
12.15 Sanquin
Exhibit 174: Sanquin - Overview
Exhibit 175: Sanquin - Product / Service
Exhibit 176: Sanquin - Key offerings
12.16 SK Inc.
Exhibit 177: SK Inc. - Overview
Exhibit 178: SK Inc. - Product / Service
Exhibit 179: SK Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 180: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 181: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 182: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 184: Inclusions checklist
Exhibit 185: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 186: Currency conversion rates for US$
13.4 Research methodology
Exhibit 187: Research methodology
Exhibit 188: Validation techniques employed for market sizing
Exhibit 189: Information sources
13.5 List of abbreviations
Exhibit 190: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global plasma fractionation market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Immunoglobulins - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Immunoglobulins - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Albumin - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Albumin - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits 47: Data Table on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits 48: Chart on Protease inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on Protease inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 54: Market opportunity by Product ($ billion)
Exhibits 55: Data Table on Market opportunity by Product ($ billion)
Exhibits 56: Chart on Application - Market share 2023-2028 (%)
Exhibits 57: Data Table on Application - Market share 2023-2028 (%)
Exhibits 58: Chart on Comparison by Application
Exhibits 59: Data Table on Comparison by Application
Exhibits 60: Chart on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Data Table on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Chart on Immunology - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Data Table on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibits 66: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits 68: Chart on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Data Table on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibits 70: Chart on Hematology - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on Hematology - Year-over-year growth 2023-2028 (%)
Exhibits 72: Chart on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Data Table on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibits 74: Chart on Critical care - Year-over-year growth 2023-2028 (%)
Exhibits 75: Data Table on Critical care - Year-over-year growth 2023-2028 (%)
Exhibits 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 78: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 80: Market opportunity by Application ($ billion)
Exhibits 81: Data Table on Market opportunity by Application ($ billion)
Exhibits 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 85: Chart on Geographic comparison
Exhibits 86: Data Table on Geographic comparison
Exhibits 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 105: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 115: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 116: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 117: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 118: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 123: Market opportunity By Geographical Landscape ($ billion)
Exhibits 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 125: Impact of drivers and challenges in 2023 and 2028
Exhibits 126: Overview on Criticality of inputs and Factors of differentiation
Exhibits 127: Overview on factors of disruption
Exhibits 128: Impact of key risks on business
Exhibits 129: Vendors covered
Exhibits 130: Matrix on vendor position and classification
Exhibits 131: ADMA Biologics Inc. - Overview
Exhibits 132: ADMA Biologics Inc. - Business segments
Exhibits 133: ADMA Biologics Inc. - Key offerings
Exhibits 134: ADMA Biologics Inc. - Segment focus
Exhibits 135: Bharat Serums and Vaccines Ltd. - Overview
Exhibits 136: Bharat Serums and Vaccines Ltd. - Product / Service
Exhibits 137: Bharat Serums and Vaccines Ltd. - Key offerings
Exhibits 138: CSL Ltd. - Overview
Exhibits 139: CSL Ltd. - Business segments
Exhibits 140: CSL Ltd. - Key offerings
Exhibits 141: CSL Ltd. - Segment focus
Exhibits 142: Emergent BioSolutions Inc. - Overview
Exhibits 143: Emergent BioSolutions Inc. - Product / Service
Exhibits 144: Emergent BioSolutions Inc. - Key news
Exhibits 145: Emergent BioSolutions Inc. - Key offerings
Exhibits 146: GC Biopharma corp. - Overview
Exhibits 147: GC Biopharma corp. - Product / Service
Exhibits 148: GC Biopharma corp. - Key offerings
Exhibits 149: Grifols SA - Overview
Exhibits 150: Grifols SA - Business segments
Exhibits 151: Grifols SA - Key offerings
Exhibits 152: Grifols SA - Segment focus
Exhibits 153: Intas Pharmaceuticals Ltd. - Overview
Exhibits 154: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits 155: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits 156: Kedrion S.p.A - Overview
Exhibits 157: Kedrion S.p.A - Product / Service
Exhibits 158: Kedrion S.p.A - Key offerings
Exhibits 159: LFB SA - Overview
Exhibits 160: LFB SA - Product / Service
Exhibits 161: LFB SA - Key offerings
Exhibits 162: Merck KGaA - Overview
Exhibits 163: Merck KGaA - Business segments
Exhibits 164: Merck KGaA - Key news
Exhibits 165: Merck KGaA - Key offerings
Exhibits 166: Merck KGaA - Segment focus
Exhibits 167: Mitsubishi Chemical Group Corp. - Overview
Exhibits 168: Mitsubishi Chemical Group Corp. - Business segments
Exhibits 169: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits 170: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits 171: Octapharma AG - Overview
Exhibits 172: Octapharma AG - Product / Service
Exhibits 173: Octapharma AG - Key offerings
Exhibits 174: Sanquin - Overview
Exhibits 175: Sanquin - Product / Service
Exhibits 176: Sanquin - Key offerings
Exhibits 177: SK Inc. - Overview
Exhibits 178: SK Inc. - Product / Service
Exhibits 179: SK Inc. - Key offerings
Exhibits 180: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 181: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 182: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 183: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 184: Inclusions checklist
Exhibits 185: Exclusions checklist
Exhibits 186: Currency conversion rates for US$
Exhibits 187: Research methodology
Exhibits 188: Validation techniques employed for market sizing
Exhibits 189: Information sources
Exhibits 190: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global plasma fractionation market: ADMA Biologics Inc., Bharat Serums and Vaccines Ltd., CSL Ltd., Emergent BioSolutions Inc., GC Biopharma corp. , Grifols SA, Hemarus Plasma, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion S.p.A, LFB SA, Merck KGaA, Mitsubishi Chemical Group Corp., Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions Netherlands BV, Sanquin, SK Inc., Takeda Pharmaceutical Co. Ltd., and Virchow Laboratories Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing elderly population and related disorders.'

According to the report, one of the major drivers for this market is the growing prevalence of plasma products treated in respiratory diseases and AATD.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ADMA Biologics Inc.
  • Bharat Serums and Vaccines Ltd.
  • CSL Ltd.
  • Emergent BioSolutions Inc.
  • GC Biopharma corp.
  • Grifols SA
  • Hemarus Plasma
  • Intas Pharmaceuticals Ltd.
  • Kamada Ltd.
  • Kedrion S.p.A
  • LFB SA
  • Merck KGaA
  • Mitsubishi Chemical Group Corp.
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • Prothya Biosolutions Netherlands BV
  • Sanquin
  • SK Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Virchow Laboratories Ltd.

Related Topics

Related Reports

Plasma Fractionation Global Market Report 2024 - Product Image

Plasma Fractionation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028 - Product Image

Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028

  • Report
  • 374 Pages
  • Global
From
Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Forecast 2024-2030 - Product Image

Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global Plasma Fractionation Market Report and Forecast 2023-2031 - Product Image

Global Plasma Fractionation Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.